Novel formulations and drug delivery systems to administer biological solids

• Published in: Advanced drug delivery reviews Vol. 172; pp. 183 - 210
• Main Authors: Zhang, Yajie, Davis, Daniel A., AboulFotouh, Khaled, Wang, Jieliang, Williams, Donna, Bhambhani, Akhilesh, Zakrewsky, Michael, Maniruzzaman, Mohammed, Cui, Zhengrong, Williams, Robert O.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.05.2021
• Subjects: Bacteriophage; Biological solids; Cell therapy; Gene therapy; Peptides; Proteins; Solid dosage forms; Vaccines; Proteins; Cell therapy; Peptides; Biological solids; Vaccines; Gene therapy; Bacteriophage; Solid dosage forms
• ISSN: 0169-409X; 1872-8294
• DOI: 10.1016/j.addr.2021.02.011

[Display omitted] Recent advances in formulation sciences have expanded the previously limited design space for biological modalities, including peptide, protein, and vaccine products. At the same time, the discovery and application of new modalities, such as cellular therapies and gene therapies, have presented formidable challenges to formulation scientists. We explore these challenges and highlight the opportunities to overcome them through the development of novel formulations and drug delivery systems as biological solids. We review the current progress in both industry and academic laboratories, and we provide expert perspectives in those settings. Formulation scientists have made a tremendous effort to accommodate the needs of these novel delivery routes. These include stability-preserving formulations and dehydration processes as well as dosing regimes and dosage forms that improve patient compliance.